Cargando…

Factors Associated with Medication Non-Adherence among Patients with Multimorbidity and Polypharmacy Admitted to an Intermediate Care Center

Identifying determinants of medication non-adherence in patients with multimorbidity would provide a step forward in developing patient-centered strategies to optimize their care. Medication appropriateness has been proposed to play a major role in medication non-adherence, reinforcing the importanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Bueno, Javier, Sevilla-Sánchez, Daniel, Puigoriol-Juvanteny, Emma, Molist-Brunet, Núria, Codina-Jané, Carles, Espaulella-Panicot, Joan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464705/ https://www.ncbi.nlm.nih.gov/pubmed/34574530 http://dx.doi.org/10.3390/ijerph18189606

Ejemplares similares

Improving individualized prescription in patients with multimorbidity through medication review
por: Molist-Brunet, Núria, et al.
Publicado: (2022)

Individualized Medication Review in Older People with Multimorbidity: A Comparative Analysis between Patients Living at Home and in a Nursing Home
por: Molist-Brunet, Núria, et al.
Publicado: (2022)

Factors Associated with the Detection of Inappropriate Prescriptions in Older People: A Prospective Cohort
por: Molist-Brunet, Núria, et al.
Publicado: (2021)

Medication Assessment in an Older Population during Acute Care Hospitalization and Its Effect on the Anticholinergic Burden: A Prospective Cohort Study
por: Espaulella-Ferrer, Mariona, et al.
Publicado: (2023)

Assessment of frailty in elderly patients attending a multidisciplinary wound care centre: a cohort study
por: Espaulella-Ferrer, Mariona, et al.
Publicado: (2021)

Traducción y adaptación transcultural al español del cuestionario ARMS para la medida de la adherencia en pacientes pluripatológicos()
por: González-Bueno, Javier, et al.
Publicado: (2017)

Therapeutic optimization through goal-oriented prescription in nursing homes
por: Molist-Brunet, N., et al.
Publicado: (2020)

Frail-VIG index: a concise frailty evaluation tool for rapid geriatric assessment
por: Amblàs-Novellas, Jordi, et al.
Publicado: (2018)

Transitions between degrees of multidimensional frailty among older people admitted to intermediate care: a multicentre prospective study
por: Amblàs-Novellas, Jordi, et al.
Publicado: (2022)

Multimorbidity or polypharmacy: two sides of the same coin?
por: Sinnott, Carol, et al.
Publicado: (2015)

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers
por: Goto, Toshihiko, et al.
Publicado: (2021)

Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022)

Pain management nursing practice assessment in older adults with dementia
por: Minaya‐Freire, Alícia, et al.
Publicado: (2021)

Effectiveness of a psychoeducational group intervention developed by primary care nurses on symptom control of pediatric patients with ADHD. ADHD parent study
por: Rodrigo Jiménez, Daniel, et al.
Publicado: (2022)

Multimorbidity and polypharmacy: a risk factor for older patients
por: Cucinotta, Domenico
Publicado: (2022)

Polypharmacy in multimorbid older adults: protocol for a systematic review
por: Sirois, Caroline, et al.
Publicado: (2017)

The evolution of an evidence based intervention designed to improve prescribing and reduce polypharmacy in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE)
por: McCarthy, Caroline, et al.
Publicado: (2020)

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice
por: von Buedingen, Fiona, et al.
Publicado: (2018)

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015
por: van den Akker, Marjan, et al.
Publicado: (2019)

Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
por: Patel, Preya Janubhai, et al.
Publicado: (2017)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
por: Villén, Noemí, et al.
Publicado: (2022)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
por: Zhao, Yong, et al.
Publicado: (2023)

Risk factors for self-reported medication adherence in community-dwelling older patients with multimorbidity and polypharmacy: a multicenter cross-sectional study
por: Liu, Jiaming, et al.
Publicado: (2023)

Medication Adherence Among Multimorbid Patients With Polypharmacy and Its Relation to Social Support at National Guard Primary Health Care Centers, Riyadh
por: Almutairi, Ahmed S, et al.
Publicado: (2022)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013
por: Lai, Shih-Wei, et al.
Publicado: (2020)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2021)

Prognostic Value of a New Tool (the 3D/3D+) for Predicting 30-Day Mortality in Emergency Department Patients Aged 75 Years and Older
por: Garcia-Pérez, Dolors, et al.
Publicado: (2023)

Sex Differences in Multimorbidity, Inappropriate Medication and Adverse Outcomes of Inpatient Care: MoPIM Cohort Study
por: Baré, Marisa, et al.
Publicado: (2023)

Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator
por: Assari, Shervin, et al.
Publicado: (2019)

Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
por: Wang, Juan, et al.
Publicado: (2022)

Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022)

Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland
por: Zechmann, Stefan, et al.
Publicado: (2019)

Combined Multimorbidity and Polypharmacy Patterns in the Elderly: A Cross-Sectional Study in Primary Health Care
por: Stafford, Grant, et al.
Publicado: (2021)

Targeting neurotransmitter-mediated inflammatory mechanisms of psychiatric drugs to mitigate the double burden of multimorbidity and polypharmacy
por: Matt, Stephanie M.
Publicado: (2021)

Correction to: Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review
por: O’Shea, Joseph, et al.
Publicado: (2022)

Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey
por: Kozieł, Monika, et al.
Publicado: (2020)

Corrigendum: Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
por: Wang, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0c77crlennvutc5hlo6titnv8e